Vertex to acquire Semma Therapeutics for £780m
Semma is engaged in developing stem cell-derived human islets used as a curative treatment for patients who currently depend on insulin injections for Type 1 Diabetes. Vertex chairman,
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XSemma is engaged in developing stem cell-derived human islets used as a curative treatment for patients who currently depend on insulin injections for Type 1 Diabetes. Vertex chairman,
US-based Paediatric hospitals Children’s National and The HSC Health Care System (HSC) have secured a regulatory approval for an integration aimed at providing care for children and young
Clinigen, a UK-based pharmaceutical and services company, and CHEPLAPHARM Arzneimittel, a Germany-based family-owned pharmaceutical company, have signed an exclusive distribution agreement for chemotherapy products Etopophos and Vepesid in
Roche has announced the extension of the offering period of its previously announced tender offer to purchase all of the outstanding shares of common stock of Spark Therapeutics
Switzerland-based healthcare company Roche announced that the European Commission has approved its Tecentriq (atezolizumab) plus chemotherapy for the treatment of adult patients with metastatic triple-negative breast cancer (TNBC).
Altais has entered into collaboration with Aledade and the California Medical Association (CMA) to offer improved patient care model supported by advanced technologies. Aledade is engaged in providing
Buddy Nutrition, a personalised nutrition platform, has launched its personalised protein powders available in several combinations, including vegan and paleo friendly choices. Buddy Nutrition, created by health and
Ascension Saint Thomas and Kindred Healthcare announced that the Tennessee State Health Services and Development Agency has granted approval for the construction and operation of a self-supporting rehabilitation
Integrated DNA Technologies (IDT) has launched oPoolsOligo Pools, a ready-to-use pools of high-quality DNA oligonucleotides (oligos) up to 350 nucleotides in length, as part of its mission to
US-based non-profit health care system AdventHealth has inaugurated the Mission Control, the mega command centre to streamline clinical operations across the health care system, in Orlando, Florida. AdventHealth